Bruno Vanderlinden

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Intra-patient comparison of tracer uptake and biodistribution of [68Ga]Ga-FAPI-46 and [18F]AlF-FAPI-74.

Intra-patient comparison of tracer uptake and biodistribution of [68Ga]Ga-FAPI-46 and [18F]AlF-FAPI-74.

Journal: Annals of nuclear medicine

Published: May 29, 2026

Quantitative accuracy of 177Lu SPECT/CT imaging using ring-shaped CZT versus dual-head NaI systems.

Quantitative accuracy of 177Lu SPECT/CT imaging using ring-shaped CZT versus dual-head NaI systems.

Journal: EJNMMI physics

Published: January 17, 2026

Multicenter comparison of radionuclide calibrators and SPECT/CT protocols for quantitative 177Lu imaging in clinical practice.

Multicenter comparison of radionuclide calibrators and SPECT/CT protocols for quantitative 177Lu imaging in clinical practice.

Journal: EJNMMI physics

Published: January 09, 2026

Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN study.

Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN study.

Journal: EJNMMI research

Published: August 27, 2024

[18F]FDG PET/CT-Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study.

[18F]FDG PET/CT-Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: August 17, 2023

Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera.

Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera.

Journal: EJNMMI physics

Published: August 07, 2023

Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study.

Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: May 09, 2023

Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.

Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.

Journal: British journal of cancer

Published: April 04, 2022

Correction to: Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.

Correction to: Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.

Journal: EJNMMI physics

Published: January 27, 2021

Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.

Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer.

Journal: EJNMMI physics

Published: March 17, 2020

Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study.

Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 05, 2019

A dosimetry procedure for organs-at-risk in 177Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours.

A dosimetry procedure for organs-at-risk in 177Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: May 17, 2018

Showing 1-12 of 28

Last Updated: 09/26/2026